BIVI
BIOVIE INC.
+0.08 (+4.65%)1.80USD346K成交股數13.6M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-09下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 4 · 49K · 4 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 49K · 0.00 |
| 近 180 天 淨額 | 49K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-28 | 08-28 | KIM JOANNE WENDY | Chief Financial Officer | P 公開市場買進 | 2.5K | 2.18 | 5K | 3.4K | SEC |
| 2026-08-28 | 08-28 | Palumbo Joseph M | Chief Medical Officer | P 公開市場買進 | 4.8K | 2.16 | 10K | 6.0K | SEC |
| 2026-08-28 | 08-28 | Chappell Amy Suzon | Director | P 公開市場買進 | 727 | 2.16 | 2K | 727 | SEC |
| 2026-08-27 | 08-28 | DO CUONG V | President & CEO | P 公開市場買進 | 15.2K | 2.08 | 32K | 16.1K | SEC |
| 2025-08-07 | 08-13 | DO CUONG V | President & CEO | P 公開市場買進 | 5.0K | – | – | 10.0K | SEC |
| 2024-11-20 | 01-07 | BERMAN RICHARD J | Director | A 獲配股票 | 34.2K | – | – | 40.6K | SEC |
| 2024-11-20 | 01-07 | ROGICH SIGMUND | Director | A 獲配股票 | 32.7K | – | – | 36.9K | SEC |
| 2024-06-24 | 07-12 | KIM JOANNE WENDY | Chief Financial Officer | F 繳稅扣股 | 18.3K | 0.47 | 9K | 93.9K | SEC |
| 2024-06-24 | 07-12 | Palumbo Joseph M | Chief Medical Officer | F 繳稅扣股 | 29.0K | 0.47 | 14K | 119K | SEC |
| 2024-06-24 | 07-12 | Palumbo Joseph M | Chief Medical Officer | A 獲配股票 | 116K | – | – | 148K | SEC |
| 2024-06-24 | 07-12 | DO CUONG V | President & CEO | A 獲配股票 | 168K | – | – | 594K | SEC |
| 2024-06-24 | 07-12 | DO CUONG V | President & CEO | F 繳稅扣股 | 42.0K | 0.47 | 20K | 552K | SEC |
| 2024-06-24 | 07-12 | KIM JOANNE WENDY | Chief Financial Officer | A 獲配股票 | 73.0K | – | – | 112K | SEC |
| 2024-03-04 | 03-06 | DO CUONG V | President & CEO | P 公開市場買進 | 10.0K | – | – | 436K | SEC |
| 2024-02-15 | 07-12 | KIM JOANNE WENDY | Chief Financial Officer | F 繳稅扣股 | 2.5K | 1.18 | 3K | 39.2K | SEC |
| 2024-02-15 | 07-12 | DO CUONG V | President & CEO | F 繳稅扣股 | 5.0K | 1.18 | 6K | 426K | SEC |
| 2024-02-15 | 07-12 | Palumbo Joseph M | Chief Medical Officer | F 繳稅扣股 | 2.5K | 1.18 | 3K | 32.2K | SEC |
| 2023-12-11 | 12-13 | KIM JOANNE WENDY | Chief Financial Officer | A 獲配股票 | 5.0K | – | – | 44.1K | SEC |
| 2023-12-01 | 12-06 | GORLIN STEVE | Director | S 公開市場賣出 | 75.7K | 1.69 | 128K | 46.4K | SEC |
| 2023-11-30 | 12-01 | DO CUONG V | President & CEO | P 公開市場買進 | 10.0K | 1.78 | 18K | 68.8K | SEC |
| 2023-11-09 | 12-06 | ROGICH SIGMUND | Director | A 獲配股票 | 42.3K | – | – | 42.3K | SEC |
| 2023-11-09 | 12-06 | BERMAN RICHARD J | Director | A 獲配股票 | 51.8K | – | – | 69.2K | SEC |
| 2023-11-09 | 12-06 | Hariri Robert J | Director | A 獲配股票 | 42.3K | – | – | 42.3K | SEC |
| 2023-11-09 | 12-06 | GORLIN STEVE | Director | A 獲配股票 | 46.4K | – | – | 122K | SEC |
| 2023-09-05 | 09-07 | GORLIN STEVE | Director | S 公開市場賣出 | 8.6K | 3.05 | 26K | 75.7K | SEC |
| 2023-08-22 | 08-24 | BERMAN RICHARD J | Director | S 公開市場賣出 | 10.8K | 3.50 | 38K | 16.8K | SEC |
| 2023-06-29 | 07-03 | DO CUONG V | CEO & President | A 獲配股票 | 150K | – | – | 426K | SEC |
| 2023-06-21 | 06-26 | DO CUONG V | CEO & President | M 選擇權執行 | 41.5K | – | – | 271K | SEC |
| 2023-06-07 | 06-15 | BERMAN RICHARD J | Director | S 公開市場賣出 | 6.0K | 5.81 | 35K | 23.2K | SEC |
| 2023-05-22 | 06-15 | BERMAN RICHARD J | Director | S 公開市場賣出 | 5.0K | 6.50 | 33K | 29.2K | SEC |
| 2023-03-28 | 04-06 | BERMAN RICHARD J | Director | S 公開市場賣出 | 2.6K | 8.52 | 22K | 34.2K | SEC |
| 2023-03-28 | 04-06 | BERMAN RICHARD J | Director | S 公開市場賣出 | 5.0K | 8.52 | 43K | 36.8K | SEC |
| 2023-03-27 | 04-06 | BERMAN RICHARD J | Director | S 公開市場賣出 | 3.4K | 8.52 | 29K | 41.8K | SEC |
| 2023-02-16 | 07-12 | DO CUONG V | President & CEO | F 繳稅扣股 | 5.0K | 5.51 | 27K | 431K | SEC |
| 2023-02-16 | 07-12 | KIM JOANNE WENDY | Chief Financial Officer | F 繳稅扣股 | 2.5K | 5.51 | 14K | 41.7K | SEC |
| 2023-02-16 | 07-12 | Palumbo Joseph M | Chief Medical Officer | F 繳稅扣股 | 2.5K | 5.51 | 14K | 34.7K | SEC |
| 2023-02-16 | 02-22 | Palumbo Joseph M | Chief Medical Officer | F 繳稅扣股 | 2.5K | 6.12 | 15K | 37.1K | SEC |
| 2023-02-16 | 02-22 | MARKHAM PENELOPE | EVP Liver Cirrhosis R&D | F 繳稅扣股 | 2.5K | 6.12 | 15K | 47.8K | SEC |
| 2023-02-16 | 02-22 | READING CHRISTOPHER | EVP Neuroscience R&D | F 繳稅扣股 | 2.5K | 6.12 | 15K | 37.1K | SEC |
| 2023-02-16 | 02-22 | Ahlem Clarence N. | EVP Neuroscience Product Dev. | F 繳稅扣股 | 2.5K | 6.12 | 15K | 37.1K | SEC |
| 2023-02-16 | 02-22 | DO CUONG V | CEO & President | F 繳稅扣股 | 5.0K | 6.12 | 30K | 230K | SEC |
| 2023-02-16 | 02-22 | KIM JOANNE WENDY | Chief Financial Officer | F 繳稅扣股 | 2.5K | 6.12 | 15K | 39.1K | SEC |
| 2022-11-23 | 01-18 | Hariri Robert J | Director | A 獲配股票 | 34.2K | – | – | 34.2K | SEC |
| 2022-11-23 | 01-18 | READING CHRISTOPHER | EVP Neuroscience R&D | A 獲配股票 | 39.6K | – | – | 39.6K | SEC |
| 2022-11-23 | 01-18 | Lang James Paul | Director | A 獲配股票 | 43.6K | – | – | 68.6K | SEC |
| 2022-11-23 | 01-18 | GORLIN STEVE | Director | A 獲配股票 | 34.2K | – | – | 84.2K | SEC |
| 2022-11-23 | 01-18 | Palumbo Joseph M | Chief Medical Officer | A 獲配股票 | 39.6K | – | – | 39.6K | SEC |
| 2022-11-23 | 01-18 | MARKHAM PENELOPE | EVP Liver Cirrhosis R&D | A 獲配股票 | 39.6K | – | – | 50.3K | SEC |
| 2022-11-23 | 01-18 | DO CUONG V | CEO & President | A 獲配股票 | 79.2K | – | – | 235K | SEC |
| 2022-11-23 | 01-18 | KIM JOANNE WENDY | Chief Financial Officer | A 獲配股票 | 39.6K | – | – | 41.6K | SEC |
| 2022-11-23 | 01-18 | BERMAN RICHARD J | Director | A 獲配股票 | 43.6K | – | – | 45.2K | SEC |
| 2022-11-23 | 01-18 | Ahlem Clarence N. | EVP Neuroscience Product Dev. | A 獲配股票 | 39.6K | – | – | 39.6K | SEC |
| 2022-08-15 | 08-16 | PEIZER TERREN S | Director,TenPercentOwner | A 獲配股票 | 3.6M | 1.65 | 6.0M | 23.2M | SEC |
| 2022-02-02 | 02-16 | Adams Jonathan M | EVP Liver Cirrhosis Programs | G 贈與 | 1.0K | – | – | 48.6K | SEC |
| 2021-12-31 | 01-25 | DO CUONG V | President & CEO | A 獲配股票 | 21.7K | – | – | 58.8K | SEC |
| 2021-12-07 | 12-09 | KIM JOANNE WENDY | CFO | P 公開市場買進 | 2.0K | 5.40 | 11K | 2.0K | SEC |
| 2021-06-16 | 10-29 | Adams Jonathan M | EVP Liver Cirrhosis Programs | G 贈與 | 10.0K | – | – | 49.6K | SEC |
| 2021-06-10 | 08-26 | PEIZER TERREN S | Director,TenPercentOwner | A 獲配股票 | 8.4M | – | – | 19.5M | SEC |
| 2020-11-03 | 12-15 | GORLIN STEVE | Director | P 公開市場買進 | 2.4K | 7.95 | 19K | 45.1K | SEC |
| 2020-10-30 | 12-15 | GORLIN STEVE | Director | P 公開市場買進 | 2.6K | 7.97 | 20K | 42.7K | SEC |
| 2020-10-21 | 10-22 | GORLIN STEVE | Director | P 公開市場買進 | 5.0K | 9.19 | 46K | 40.1K | SEC |
| 2020-10-15 | 10-19 | GORLIN STEVE | Director | P 公開市場買進 | 100 | 10.27 | 1K | 20.1K | SEC |
| 2020-10-15 | 10-19 | GORLIN STEVE | Director | P 公開市場買進 | 1.0K | 10.18 | 10K | 21.1K | SEC |
| 2020-10-15 | 10-19 | GORLIN STEVE | Director | P 公開市場買進 | 5.0K | 10.01 | 50K | 35.1K | SEC |
| 2020-10-15 | 10-19 | GORLIN STEVE | Director | P 公開市場買進 | 4.0K | 10.19 | 41K | 25.1K | SEC |
| 2020-10-15 | 10-19 | GORLIN STEVE | Director | P 公開市場買進 | 5.0K | 10.10 | 51K | 30.1K | SEC |
| 2020-10-09 | 10-14 | GORLIN STEVE | Director | P 公開市場買進 | 282 | 9.61 | 3K | 20.0K | SEC |
| 2020-10-07 | 10-14 | GORLIN STEVE | Director | P 公開市場買進 | 4.7K | 9.42 | 44K | 19.7K | SEC |
| 2020-09-22 | 08-26 | PEIZER TERREN S | Director,TenPercentOwner | M 選擇權執行 | 1.5M | – | – | 11.2M | SEC |
| 2020-09-22 | 08-26 | PEIZER TERREN S | Director,TenPercentOwner | A 獲配股票 | 5.4M | – | – | 9.6M | SEC |
| 2020-09-22 | 10-14 | GORLIN STEVE | Director | P 公開市場買進 | 15.0K | 10.00 | 150K | 15.0K | SEC |
| 2020-01-02 | 08-26 | PEIZER TERREN S | Director,TenPercentOwner | A 獲配股票 | 1.6K | – | – | 4.3M | SEC |
| 2020-01-02 | 08-26 | PEIZER TERREN S | Director,TenPercentOwner | A 獲配股票 | 4.4K | – | – | 4.3M | SEC |
| 2020-01-02 | 09-29 | BERMAN RICHARD J | Director | A 獲配股票 | 1.6K | – | – | 1.6K | SEC |
| 2020-01-02 | 10-21 | Sherman Michael Edward | Director | A 獲配股票 | 1.6K | 3.50 | 6K | 20.7K | SEC |
| 2020-01-02 | 10-21 | Do Cuong V | Director | A 獲配股票 | 1.6K | 3.50 | 6K | 96.8K | SEC |
| 2020-01-02 | 10-21 | Lang James Paul | Director | A 獲配股票 | 1.6K | 3.50 | 6K | 25.0K | SEC |
| 2019-09-24 | 08-26 | PEIZER TERREN S | Director,TenPercentOwner | A 獲配股票 | 1.1M | – | – | 4.3M | SEC |
| 2019-06-24 | 08-26 | PEIZER TERREN S | Director,TenPercentOwner | A 獲配股票 | 1.5M | 45.00 | 68.7M | 3.1M | SEC |
| 2019-01-02 | 08-26 | PEIZER TERREN S | Director,TenPercentOwner | A 獲配股票 | 1.6K | – | – | 1.6M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| MORGAN STANLEY | 605K | 1.2M | 新進 | 新進 |
| Diametric Capital, LP | 257K | 498K | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 128K | 248K | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 96.0K | 186K | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 70.9K | 138K | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 70.8K | 137K | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 37.6K | 73K | 新進 | 新進 |
| JANE STREET GROUP, LLC | 35.9K | 70K | 新進 | 新進 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32.6K | 63K | 新進 | 新進 |
| NORTHERN TRUST CORP | 21.8K | 42K | 新進 | 新進 |
| Persistent Asset Partners Ltd | 15.0K | 29K | 新進 | 新進 |
| XTX Topco Ltd | 14.2K | 28K | 新進 | 新進 |
| Caprock Group, LLC | 11.3K | 22K | 新進 | 新進 |
| Allworth Financial LP | 5.6K | 11K | 新進 | 新進 |
| UBS Group AG | 2.2K | 4K | 新進 | 新進 |
| Tower Research Capital LLC (TRC) | 2.1K | 4K | 新進 | 新進 |
| PNC Financial Services Group, Inc. | 1.0K | 2K | 新進 | 新進 |
| SBI Securities Co., Ltd. | 867 | 2K | 新進 | 新進 |
| Integrated Wealth Concepts LLC | 86 | 166.00 | 新進 | 新進 |
| PHILADELPHIA TRUST CO | 50.0K | 97.00 | 新進 | 新進 |
| Cambridge Investment Research Advisors, Inc. | 27.6K | 54.00 | 新進 | 新進 |
| Caitong International Asset Management Co., Ltd | 14 | 27.00 | 新進 | 新進 |
| Tradewinds Capital Management, LLC | 10 | 20.00 | 新進 | 新進 |
| NewEdge Advisors, LLC | 10 | 19.00 | 新進 | 新進 |
| WELLS FARGO & COMPANY/MN | 10 | 19.00 | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 36 +2 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 36 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 1.5M · 19.7% |
| 合計季末市值 | 2.7M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 885K |
|---|---|
| 與上期比 | -29.5% |
| 佔流通股數 | 11.73% |
| 日均成交量 | 11.8M |
| 回補天數 | 1.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 885K | -29.5% | 11.73% | 11.8M | 1.0 |
| 2026-08-14 | 1.3M | +56.7% | 16.63% | 15.0M | 1.0 |
| 2026-07-31 | 801K | +22.2% | 10.61% | 180K | 4.4 |
| 2026-07-15 | 655K | +45.9% | 8.69% | 256K | 2.6 |
| 2026-06-30 | 449K | +49.5% | 5.95% | 223K | 2.0 |
| 2026-06-15 | 300K | +59.3% | 3.98% | 121K | 2.5 |
| 2026-05-29 | 188K | -0.4% | 2.50% | 92.4K | 2.0 |
| 2026-05-15 | 189K | +6.9% | 2.51% | 118K | 1.6 |
| 2026-04-30 | 177K | +37.0% | 2.35% | 87.1K | 2.0 |
| 2026-04-15 | 129K | -16.2% | 1.71% | 56.0K | 2.3 |
| 2026-03-31 | 154K | +1.0% | 2.04% | 69.1K | 2.2 |
| 2026-03-13 | 153K | +7.7% | 2.02% | 62.3K | 2.5 |
| 2026-02-27 | 142K | -20.3% | 1.88% | 103K | 1.4 |
| 2026-02-13 | 178K | -8.7% | 2.36% | 126K | 1.4 |
| 2026-01-30 | 195K | +27.2% | 2.58% | 92.5K | 2.1 |
| 2026-01-15 | 153K | -10.3% | 2.03% | 116K | 1.3 |
| 2025-12-31 | 171K | +0.7% | 2.26% | 136K | 1.3 |
| 2025-12-15 | 170K | +0.8% | 2.25% | 56.5K | 3.0 |
| 2025-11-28 | 168K | -3.5% | 2.23% | 70.1K | 2.4 |
| 2025-11-14 | 174K | -18.2% | 2.31% | 106K | 1.6 |
| 2025-10-31 | 213K | +32.7% | 2.82% | 102K | 2.1 |
| 2025-10-15 | 161K | +6.7% | 2.13% | 212K | 1.0 |
| 2025-09-30 | 150K | -16.0% | 2.00% | 184K | 1.0 |
| 2025-09-15 | 179K | +3.5% | 2.37% | 404K | 1.0 |
| 2025-08-29 | 173K | +7.3% | 2.30% | 243K | 1.0 |
| 2025-08-15 | 161K | +22.1% | 2.14% | 648K | 1.0 |